These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36683367)

  • 1. A Patent Review on Cardiotoxicity of Anticancerous Drugs.
    Bhadana R; Rani V
    Cardiovasc Hematol Agents Med Chem; 2023 Jan; ():. PubMed ID: 36683367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced cardiac toxicity and adverse drug reactions, a narrative review.
    Destere A; Merino D; Lavrut T; Rocher F; Viard D; Drici MD; Gérard AO
    Therapie; 2024; 79(2):161-172. PubMed ID: 37957054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guarding the heart: How SGLT-2 inhibitors protect against chemotherapy-induced cardiotoxicity: SGLT-2 inhibitors and chemotherapy-induced cardiotoxicity.
    Vafa RG; Sabahizadeh A; Mofarrah R
    Curr Probl Cardiol; 2024 Mar; 49(3):102350. PubMed ID: 38128634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Manifestations, Monitoring, and Prognosis: A Review of Cardiotoxicity After Antitumor Strategy.
    Huang W; Xu R; Zhou B; Lin C; Guo Y; Xu H; Guo X
    Front Cardiovasc Med; 2022; 9():912329. PubMed ID: 35757327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity.
    Ma W; Wei S; Zhang B; Li W
    Front Cell Dev Biol; 2020; 8():434. PubMed ID: 32582710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.
    Rygiel K
    Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase II
    Kollárová-Brázdová P; Jirkovská A; Karabanovich G; Pokorná Z; Bavlovič Piskáčková H; Jirkovský E; Kubeš J; Lenčová-Popelová O; Mazurová Y; Adamcová M; Skalická V; Štěrbová-Kovaříková P; Roh J; Šimůnek T; Štěrba M
    J Pharmacol Exp Ther; 2020 Jun; 373(3):402-415. PubMed ID: 32253261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity of Targeted Cancer Drugs: Concerns, "The Cart Before the Horse," and Lessons from Trastuzumab.
    Menna P; Minotti G; Salvatorelli E
    Curr Cardiol Rep; 2019 Mar; 21(5):33. PubMed ID: 30887161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
    Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.
    Zambelli A; Della Porta MG; Eleuteri E; De Giuli L; Catalano O; Tondini C; Riccardi A
    Breast; 2011 Apr; 20(2):176-83. PubMed ID: 21146409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
    Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
    Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection.
    Morelli MB; Bongiovanni C; Da Pra S; Miano C; Sacchi F; Lauriola M; D'Uva G
    Front Cardiovasc Med; 2022; 9():847012. PubMed ID: 35497981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity.
    Schwach V; Slaats RH; Passier R
    Front Cardiovasc Med; 2020; 7():50. PubMed ID: 32322588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial.
    Čiburienė E; Aidietienė S; Ščerbickaitė G; Sadauskienė E; Sudavičienė D; Baltruškevičienė E; Brasiūnienė B; Drobnienė M; Čelutkienė J
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138243
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced mitochondrial dysfunction and cardiotoxicity.
    Varga ZV; Ferdinandy P; Liaudet L; Pacher P
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1453-67. PubMed ID: 26386112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and solutions in management of cardiotoxicity induced by checkpoint inhibitors.
    Mladosievičová B; Országhová Z; Jablonická M; Rečková M; Chovanec M; Mego M
    Klin Onkol; 2020; 33(5):350-355. PubMed ID: 33108879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors.
    Maurea N; Coppola C; Piscopo G; Galletta F; Riccio G; Esposito E; De Lorenzo C; De Laurentiis M; Spallarossa P; Mercuro G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e19-e26. PubMed ID: 27755239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity linked to anticancer agents and cardioprotective strategy.
    Khairnar SI; Kulkarni YA; Singh K
    Arch Pharm Res; 2022 Oct; 45(10):704-730. PubMed ID: 36306018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity.
    Luo X
    Environ Res; 2023 Dec; 238(Pt 2):116989. PubMed ID: 37633635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.
    Jain D; Russell RR; Schwartz RG; Panjrath GS; Aronow W
    Curr Cardiol Rep; 2017 May; 19(5):36. PubMed ID: 28374177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.